Inventor

TOOGOOD PETER L

US15 patents

⚠️ This page may combine multiple inventors who share the name “TOOGOOD PETER L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LYCERA CORP

9 patents

US9394315B2Jul 19, 2016

Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

LYCERA CORP15 citations92

US10208061B2Feb 19, 2019

Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

LYCERA CORP6 citations83

US9802958B2Oct 31, 2017

Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease

LYCERA CORP7 citations83

US9221814B2Dec 29, 2015

Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof

LYCERA CORP8 citations83

US9580391B2Feb 28, 2017

Saturated acyl guanidine for inhibition of F1F0-ATPase

LYCERA CORP4 citations72

US10532088B2Jan 14, 2020

Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods

LYCERA CORP2 citations68

US10112935B2Oct 30, 2018

Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

LYCERA CORP1 citations51

US9920012B2Mar 20, 2018

Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof

LYCERA CORP1 citations50

US10556898B2Feb 11, 2020

Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

LYCERA CORP0 citations40

MERCK SHARP & DOHME

3 patents

US9657033B2May 23, 2017

Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

MERCK SHARP & DOHME20 citations91

US9266827B2Feb 23, 2016

Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME23 citations91

US10377768B2Aug 13, 2019

Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME6 citations82

GLICK GARY D

1 patent

US9512111B2Dec 6, 2016

N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

GLICK GARY D21 citations81

HURD ALEXANDER R

1 patent

US9169199B2Oct 27, 2015

Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof

HURD ALEXANDER R8 citations78

WARNER LAMBERT CO

1 patent

US6982260B1Jan 3, 2006

Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes

WARNER LAMBERT CO5 citations58